Short answer · Medically reviewed summary · Last updated: 2026-04-07
Floating-Harbor syndrome is currently classified under the ICD-10 code Q87.89 (Other specified congenital malformation syndromes, not elsewhere classified) and does not have a unique, specific code in the older ICD-9 system, where it would typically fall under 759.89 (Other specified congenital anomalies). Because Floating-Harbor syndrome is a rare genetic disorder, it is often documented using these broader "catch-all" codes in medical billing and clinical coding systems. What is the clinical significance of Floating-Harbor syndrome? Floating-Harbor syndrome, also known as Pelletier-Leisti syndrome, is a rare genetic condition characterized by distinctive craniofacial features, short stature, and significant expressive language delays.
Floating-Harbor syndrome is currently classified under the ICD-10 code Q87.89 (Other specified congenital malformation syndromes, not elsewhere classified) and does not have a unique, specific code in the older ICD-9 system, where it would typically fall under 759.89 (Other specified congenital anomalies). Because Floating-Harbor syndrome is a rare genetic disorder, it is often documented using these broader "catch-all" codes in medical billing and clinical coding systems.
Floating-Harbor syndrome, also known as Pelletier-Leisti syndrome, is a rare genetic condition characterized by distinctive craniofacial features, short stature, and significant expressive language delays. The condition was first described in the 1970s and is caused by heterozygous mutations in the SRCAP gene. For the 11 individuals with Floating-Harbor syndrome who have connected through the DiseaseMaps.org community, these clinical labels are more than just billing codes; they represent a journey toward understanding a complex developmental profile that requires a multidisciplinary approach to care.
Diagnosis of Floating-Harbor syndrome is primarily clinical, based on the presence of a triangular face, deep-set eyes, a prominent nose with a narrow bridge, and delayed bone age. Following a clinical suspicion, molecular genetic testing is used to confirm a mutation in the SRCAP gene. Because there is no dedicated ICD-10 code specifically for Floating-Harbor syndrome, clinicians often use the following strategies for accurate medical documentation:
Individuals living with Floating-Harbor syndrome often face a unique set of challenges that extend beyond the physical phenotype. While the prevalence remains unknown, it is considered extremely rare, with fewer than 100 cases reported in medical literature worldwide. Key features typically observed include:
Due to the rarity of Floating-Harbor syndrome, many general practitioners may not be familiar with the diagnostic criteria or the specific coding requirements. This can lead to delays in diagnosis and challenges in accessing specialized therapies. Connecting with rare disease communities like DiseaseMaps.org allows families to share experiences regarding how they navigate these administrative hurdles, ensuring that the clinical focus remains on the developmental and medical needs of the patient rather than the limitations of the coding system.
Medical disclaimer: This information is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider.